These findings strongly support our guiding hypothesis—formed from both clinical and mechanistic insights—that estrogen deficiency contributes to FECD progression, and that E2 exerts a cytoprotective effect by modulating TGF-β–driven fibrosis. Here, TGFB1 is linked to Fuchs endothelial corneal dystrophy.